Gene Therapy and Rare Diseases
•
0 likes•189 views
Todd Berner talks about the growing potential for gene therapy methods to treat rare diseases that previously would have been difficult to effectively address.
Report
Share
Report
Share
Download to read offline
Recommended
How COVID-19 Is Changing Digital Health
In need of an update, existing healthcare infrastructure has been revamped during COVID-19, while telehealth has become a priority for many organizations.
Tips For A Great Telehealth Patient Experience
In the face of a global pandemic, healthcare organizations have been forced to adjust their approach to telehealth. Here's how any healthcare professional can remotely connect with their patients.
Genetic Testing Today | Todd Berner
Genetic testing has already done a lot to contribute to our understanding of rare diseases as well as the development of specialized treatments.
Staying Productive in the Face of Clinician Burnout
Clinician burnout is driving many to early retirement or to leave the healthcare industry. Hospitals should approach this issue as a long-term investment and plan to support their doctors.
Benefits of Mobile Health Clinics
Mobile health clinics are helping to address barriers to healthcare for vulnerable populations, including location, price, and lack of insurance.
Behind the Consumerization of Healthcare
For hospitals and other healthcare facilities, it's important to realize that delivering a great service is more important than ever in the face of consumers comparison shopping.
Recommended
How COVID-19 Is Changing Digital Health
In need of an update, existing healthcare infrastructure has been revamped during COVID-19, while telehealth has become a priority for many organizations.
Tips For A Great Telehealth Patient Experience
In the face of a global pandemic, healthcare organizations have been forced to adjust their approach to telehealth. Here's how any healthcare professional can remotely connect with their patients.
Genetic Testing Today | Todd Berner
Genetic testing has already done a lot to contribute to our understanding of rare diseases as well as the development of specialized treatments.
Staying Productive in the Face of Clinician Burnout
Clinician burnout is driving many to early retirement or to leave the healthcare industry. Hospitals should approach this issue as a long-term investment and plan to support their doctors.
Benefits of Mobile Health Clinics
Mobile health clinics are helping to address barriers to healthcare for vulnerable populations, including location, price, and lack of insurance.
Behind the Consumerization of Healthcare
For hospitals and other healthcare facilities, it's important to realize that delivering a great service is more important than ever in the face of consumers comparison shopping.
The Case For And Against Patient Portals
Though patient portals have enjoyed widespread adoption among healthcare professionals, patients have been much more apathetic. How can organizations listen to patients and make these tools more palatable?
Patient Engagement Is Not One Size Fits All
Patient engagement shouldn't be all about technology. Rather, care providers owe it to their patients to determine the best ways to get them involved in their health and ensure the best outcomes for them.
Why Patient Advocacy Matters
Patient advocacy is especially important for those living with rare diseases. As the potential to cure some of these conditions rises with the advent of gene therapy, advocacy groups will need to ensure ethical testing and implementation of new solutions.
The Role of Pharma in Future Healthcare
Pharmaceutical companies are reevaluating the way they help patients. From better production and distribution of medicine to improvements in patient engagement, the future looks highly dependent on innovative technology and better communication.
VR in Medical Training
Virtual reality has become a popular technology for entertainment in recent years, but it has other applications as well. Learn about how VR can be used to prepare aspiring doctors and surgeons for working with patients.
Unventured Territory—Venture Capitalists Tackle Healthcare Issues
With an aging population and aging patient care systems, venture capitalists have risen to the challenge of revamping America's healthcare system.
The CRISPR Controversy—The Debate Over Genetic Manipulation
Todd Berner gives a rundown of recent news and developments on CRISPR, a genetic manipulation tool creating a buzz in the scientific community for its potential applications and debatable ownership.
Go Big or Go Home—The Data Boon in Healthcare
Big Data has the potential to give us insights into our own physical conditions more than ever before. Read about some of the best applications for this new trend.
How the Saints Triumphed Over the 49ers
Todd Berner talks about the Saints recent win over San Francisco 49ers.
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner talks about the prominent role of payer ACOs in the modern healthcare industry.
Generating Quality Data through Collaborative Research with an ACO
Todd Berner's presentation outlining how to generate quality data through collaborative research with an ACO.
Mirabegron US Commercial Persistence poster AUGS 2014
EArly Experience with Mirabegron: Comparative Persistence of Mirabegron and Tolterodine Extended release in Patients with Overactive Bladder AUGS poster 2014
OAB and UI AGS poster apr 24 2015
Challenges in the Management of Nursing Home Residents with Overactive Bladder and/or Urinary Incontinence
Humana PIMS AGS poster 2015
Impact of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Costs in Patients with Overactive Bladder
Overactive Bladder Cost Effectiveness Comparisons AGS poster 2015
Cost Effectiveness Comparisons for Overactive Bladder Medications Poster from American Geriatrics Society 2015 Annual meeting
Indiana University Anticholinergic Burden Scale 2012
Indiana University Regenstrief Institute Anticholinergic Cognitive Burden Scale 2012
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Todd Berner's presentation: Disseminate Clinical Data Early to Support Payer Coverage Decisions
Health Economics Research:
Collaborating with ACOs to Improve Patient Data
Todd Berner's presentation. Health Economics Research:
Collaborating with ACOs to Improve Patient Data
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
More Related Content
More from Todd Berner MD
The Case For And Against Patient Portals
Though patient portals have enjoyed widespread adoption among healthcare professionals, patients have been much more apathetic. How can organizations listen to patients and make these tools more palatable?
Patient Engagement Is Not One Size Fits All
Patient engagement shouldn't be all about technology. Rather, care providers owe it to their patients to determine the best ways to get them involved in their health and ensure the best outcomes for them.
Why Patient Advocacy Matters
Patient advocacy is especially important for those living with rare diseases. As the potential to cure some of these conditions rises with the advent of gene therapy, advocacy groups will need to ensure ethical testing and implementation of new solutions.
The Role of Pharma in Future Healthcare
Pharmaceutical companies are reevaluating the way they help patients. From better production and distribution of medicine to improvements in patient engagement, the future looks highly dependent on innovative technology and better communication.
VR in Medical Training
Virtual reality has become a popular technology for entertainment in recent years, but it has other applications as well. Learn about how VR can be used to prepare aspiring doctors and surgeons for working with patients.
Unventured Territory—Venture Capitalists Tackle Healthcare Issues
With an aging population and aging patient care systems, venture capitalists have risen to the challenge of revamping America's healthcare system.
The CRISPR Controversy—The Debate Over Genetic Manipulation
Todd Berner gives a rundown of recent news and developments on CRISPR, a genetic manipulation tool creating a buzz in the scientific community for its potential applications and debatable ownership.
Go Big or Go Home—The Data Boon in Healthcare
Big Data has the potential to give us insights into our own physical conditions more than ever before. Read about some of the best applications for this new trend.
How the Saints Triumphed Over the 49ers
Todd Berner talks about the Saints recent win over San Francisco 49ers.
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner talks about the prominent role of payer ACOs in the modern healthcare industry.
Generating Quality Data through Collaborative Research with an ACO
Todd Berner's presentation outlining how to generate quality data through collaborative research with an ACO.
Mirabegron US Commercial Persistence poster AUGS 2014
EArly Experience with Mirabegron: Comparative Persistence of Mirabegron and Tolterodine Extended release in Patients with Overactive Bladder AUGS poster 2014
OAB and UI AGS poster apr 24 2015
Challenges in the Management of Nursing Home Residents with Overactive Bladder and/or Urinary Incontinence
Humana PIMS AGS poster 2015
Impact of Potentially Inappropriate Use of Antimuscarinic Medications on Healthcare Costs in Patients with Overactive Bladder
Overactive Bladder Cost Effectiveness Comparisons AGS poster 2015
Cost Effectiveness Comparisons for Overactive Bladder Medications Poster from American Geriatrics Society 2015 Annual meeting
Indiana University Anticholinergic Burden Scale 2012
Indiana University Regenstrief Institute Anticholinergic Cognitive Burden Scale 2012
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Todd Berner's presentation: Disseminate Clinical Data Early to Support Payer Coverage Decisions
Health Economics Research:
Collaborating with ACOs to Improve Patient Data
Todd Berner's presentation. Health Economics Research:
Collaborating with ACOs to Improve Patient Data
More from Todd Berner MD (20)
Unventured Territory—Venture Capitalists Tackle Healthcare Issues
Unventured Territory—Venture Capitalists Tackle Healthcare Issues
The CRISPR Controversy—The Debate Over Genetic Manipulation
The CRISPR Controversy—The Debate Over Genetic Manipulation
Todd Berner: Assessment of Payer ACOs: Industry's Role
Todd Berner: Assessment of Payer ACOs: Industry's Role
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
Berner T Health Economics Research Collaborating with ACOs to Improve Patient...
Berner T Health Economics Research Collaborating with ACOs to Improve Patient...
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACO
Mirabegron US Commercial Persistence poster AUGS 2014
Mirabegron US Commercial Persistence poster AUGS 2014
Overactive Bladder Cost Effectiveness Comparisons AGS poster 2015
Overactive Bladder Cost Effectiveness Comparisons AGS poster 2015
Indiana University Anticholinergic Burden Scale 2012
Indiana University Anticholinergic Burden Scale 2012
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Disseminate Clinical Data Early to Support Payer Coverage Decisions
Health Economics Research:
Collaborating with ACOs to Improve Patient Data
Health Economics Research:
Collaborating with ACOs to Improve Patient Data
Recently uploaded
NVBDCP.pptx Nation vector borne disease control program
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ocular injury ppt Upendra pal optometrist upums saifai etawah
This ppt are composed by upendra pal to provide help future optometrist of india
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
A Classical Text Review on Basavarajeeyam
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Gram Stain introduction, principle, Procedure
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnataka
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
CDSCO and Phamacovigilance {Regulatory body in India}
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications. Reference - ASCRS textbook of colorectal surgery, Anorectal physiology - lucia olivia.
Bailey and love- 28th edition
micro teaching on communication m.sc nursing.pdf
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Recently uploaded (20)
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh